Filing Details
- Accession Number:
- 0001209191-14-070905
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-24 18:37:52
- Reporting Period:
- 2014-11-20
- Filing Date:
- 2014-11-24
- Accepted Time:
- 2014-11-24 18:37:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1423824 | Alder Biopharmaceuticals Inc | ALDR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604834 | James Mark Litton | 11804 North Creek Parkway South Bothell WA 98011 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-11-20 | 30,000 | $15.63 | 88,484 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 30,000 | Indirect | Held in trust for the benefit of Reporting Person's minor child |
Common Stock | 30,000 | Indirect | Held in trust for the benefit of Reporting Person's minor child |
Common Stock | 30,000 | Indirect | Held in trust for the benefit of Reporting Person's minor child |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.21 to $16.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.